Cleave Therapeutics
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Launch date
Employees
Market cap
-
Enterprise valuation
€44—65m (Dealroom.co estimates Aug 2019.)
San Francisco California (HQ)
Authorizing premium user...